학술논문

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study
Document Type
Article
Source
In eClinicalMedicine September 2022 51
Subject
Language
ISSN
2589-5370